TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway.
TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway.
复制标题
TRAF6通过c-Jun/ATG16L2信号通路调控黑色素瘤细胞的自噬和凋亡。
作者:
Guo, Yeye;Zhang, Xu;Li, Jie;Zhou, Zhe;Zhu, Susi;Liu, Waner;Su, Juan;Chen, Xiang;Peng, Cong
Autophagy and apoptosis are essential processes that participate in cell death and maintain cellular homeostasis. Dysregulation of these biological processes results in the development of diseases, including cancers. Therefore, targeting the interaction between apoptosis and autophagy offers a potential strategy for cancer therapy. Melanoma is the most lethal skin cancer. We previously found that tumor necrosis factor receptor‐associated factor 6 (TRAF6) is overexpressed in melanoma and benefits the malignant phenotype of melanoma cells. Additionally, TRAF6 promotes the activation of cancer‐associated fibroblasts in melanoma. However, the role of TRAF6 in autophagy and apoptosis remains unclear. In this study, we found that knockdown of TRAF6 induced both apoptosis and autophagy in melanoma cells. Transcriptomic data and real‐time PCR analysis demonstrated reduced expression of autophagy related 16 like 2 (ATG16L2) in TRAF6‐deficient melanoma cells. ATG16L2 knockdown resulted in increased autophagy and apoptosis. Mechanism studies confirmed that TRAF6 regulated ATG16L2 expression through c‐Jun. Importantly, targeting TRAF6 with cinchonine, a TRAF6 inhibitor, effectively suppressed the growth of melanoma cells by inducing autophagy and apoptosis through the TRAF6/c‐Jun/ATG16L2 signaling pathway. These findings highlight the pivotal role of TRAF6 in regulating autophagy and apoptosis in melanoma, emphasizing its significance as a novel therapeutic target for melanoma treatment. TRAF6 promotes the transcriptional activity of c‐Jun, resulting in the upregulation of ATG16L2. This signaling pathway plays a pivotal role in the regulation of apoptosis and autophagy in melanoma cells. Inhibition of TRAF6 using cinchonine effectively suppresses melanoma cell growth by inducing apoptosis and autophagy. Our findings highlight the therapeutic potential of targeting the TRAF6‐c‐Jun/ATG16L2 axis in melanoma treatment.
登录
查看更多内容
DOI:
10.1016/j.jid.2020.03.943
发表时间:
2021-01
期刊:
The Journal of investigative dermatology
影响因子:
--
作者:
Jenkins RW;Fisher DE
通讯作者:
Fisher DE
影响因子:
--
作者:
Brentnall M;Rodriguez-Menocal L;De Guevara RL;Cepero E;Boise LH
通讯作者:
Boise LH
影响因子:
13.3
作者:
Akar, Ugur;Chaves-Reyez, Arturo;Ozpolat, Bulent
通讯作者:
Ozpolat, Bulent
影响因子:
6.5
作者:
Guo, Yeye;Zhang, Xu;Peng, Cong
通讯作者:
Peng, Cong
影响因子:
5.2
作者:
Busch J;Moreno R;de la Vega L;Saul VV;Bacher S;von Zweydorf F;Ueffing M;Weber A;Gloeckner CJ;Linne U;Kracht M;Schmitz ML
通讯作者:
Schmitz ML